目标试验模拟评估口服药物安全性:噻嗪类与龋齿风险
本研究应用目标试验模拟框架,利用All of Us研究计划的电子健康记录,采用活性对照新用户设计,比较噻嗪类与非噻嗪类单药治疗5年龋齿风险。目标试验模拟队列显示两组5年龋齿风险差异无统计学意义(风险差0.29%,95%CI -0.36%至0.95%),而朴素队列显示方向相反的效果,凸显设计相关偏倚的影响。
要点
- 目标试验模拟可减少观察性研究中的常见偏倚,在特定条件下支持因果解释。
- 噻嗪类单药治疗与非噻嗪类单药治疗的5年龋齿风险差异无统计学意义。
- 朴素队列(流行用户队列和非对齐队列)显示与目标试验模拟相反的方向性效果。
核心结论
- 在目标试验模拟队列中,噻嗪类与非噻嗪类单药治疗的5年龋齿风险差异无统计学意义,风险差为0.29%(95%CI -0.36%至0.95%)。
- 朴素队列显示方向相反的效果,流行用户队列5年风险差为0.65%(95%CI 0.22%至1.09%),非对齐队列为-0.24%(95%CI -0.55%至0.07%),提示设计相关偏倚的影响。
研究设计与样本
- 研究应用目标试验框架构建目标试验模拟队列,采用活性对照新用户设计。
- 数据来源为All of Us研究计划的电子健康记录,比较噻嗪类与非噻嗪类单药治疗。
- 同时构建两个朴素队列:流行用户队列(包含现有用药者)和非对齐队列(受不死时间偏倚影响)。
主要发现
- 目标试验模拟队列中,噻嗪类与非噻嗪类单药治疗的5年龋齿风险差异为0.29%(95%CI -0.36%至0.95%)。
- 流行用户队列的5年风险差为0.65%(95%CI 0.22%至1.09%)。
- 非对齐队列的5年风险差为-0.24%(95%CI -0.55%至0.07%)。
临床怎么用
- 目标试验模拟框架可用于口腔健康领域的观察性研究,帮助避免常见偏倚并支持因果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Trials that use a randomization process are preferred for evaluating causal effect. However, these interventional studies are not always feasible due to ethical, time, and cost constraints. Additionally, they are often criticized for not accurately representing patients seen in clinical practice. Observational studies can help bridge this gap, but they are often affected by several sources of bias. A growing framework known as target trial emulation (TTE) is increasingly being applied to real-world data to minimize these common biases in observational studies and, under certain conditions, allow for causal interpretation. In this study, we assessed the 5-y effect of thiazide monotherapy, an antihypertensive medication known to cause xerostomia, on the risk of developing dental caries. We applied the target trial framework to build a TTE cohort using an active comparator new user design. We compared thiazide vs nonthiazide monotherapy using electronic health records from the All of Us Research Program. Furthermore, we developed 2 naïve cohorts: a prevalent user cohort, which included existing medication users, and a nonaligned cohort, which was affected by immortal time bias. These cohorts helped illustrate the advantages of TTE. In the TTE cohort, we found no significant difference in the 5-y risk of dental caries between groups, with a risk difference of 0.29% (95% CI, -0.36% to 0.95%). In contrast, the naïve cohorts showed directionally opposite effects, with 5-y risk differences of 0.65% (95% CI, 0.22% to 1.09%) in the prevalent user cohort and -0.24% (95% CI, -0.55% to 0.07%) in the nonaligned cohort, highlighting the impact of design-related biases on the observed outcomes. We demonstrated how the TTE framework can help avoid common biases in observational research, enabling researchers to answer important oral health questions.
引用
- Leiva-Escobar I, Puzhakkara Chennas A, Reckelkamm SL, et al. Target Trial Emulation to Assess Oral Drug Safety. J Dent Res. 2026. PMID: 41846520. doi:10.1177/00220345261429938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。